NetworkNewsBreaks – CURE Pharmaceutical (CURR) Appoints Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) Chairman, John K. Bell, to Board of Directors
CURE Pharmaceutical (OTCQB: CURR), an innovative drug delivery and development company, recently announced the appointment of John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to Cure Pharmaceutical, most recently serving as chairman of the Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) board of directors. “John’s unparalleled depth and breadth of expertise makes him an invaluable asset to our growth strategy,” CURE Pharmaceutical CEO Rob Davidson said in the news release. “His impressive array of experience supports every aspect of our business, including pharmaceutical, manufacturing, financial and cannabis.” To view…







